CHITOSAN NANOPARTICLES MEDIATED DELIVERY OF MIR-106B-5P TO BREAST CANCER CELL LINES MCF-7 AND T47D

Rizkita, Leonny (2021) CHITOSAN NANOPARTICLES MEDIATED DELIVERY OF MIR-106B-5P TO BREAST CANCER CELL LINES MCF-7 AND T47D. innovareacademics.in.

[thumbnail of Peer Review dr. Leonny Dwi R .pdf] Text
Peer Review dr. Leonny Dwi R .pdf

Download (748kB)
[thumbnail of CHITOSAN NANOPARTICLES MEDIATED DELIVERY MIR-106B-5P ON BREAST CANCER CELL LINE MCF-7 AND T47D.pdf] Text
CHITOSAN NANOPARTICLES MEDIATED DELIVERY MIR-106B-5P ON BREAST CANCER CELL LINE MCF-7 AND T47D.pdf

Download (2MB)

Abstract

ABSTRACT
Objective: The development of nanomedicine, such as miRNA transfection to cancer cells, has widely gained interest in the past decade.
Unfortunately, miRNA tends to decay easily by the cellular enzymatic process and requires a carrier. As a cationic biopolymer, chitosan is widely
known as a non-viral vector. However, research about chitosan as a miRNA delivery system remains limited. This study aimed to investigate the
effect and characters of synthetic miRNA loaded chitosan nanoparticles on breast cancer cell lines.
Methods: To obtain the nanocomplex, chitosan-antimiR-106b-5p was formulated using natrium tripolyphosphate through ionic gelation methods.
The nanochitosan formula was characterized by using gel electrophoresis; Nano Quant for encapsulation of entrapment quantification; morphology
appearance as viewed by Scanning Electron Microscope (SEM), nanochitosan size analysis; in vitro analysis using MCF-7 and T47D breast cancer cell
lines; in silico prediction of possible gene target; polymerase chain reaction analysis and gel electrophoresis for E2F1/GAPDH expression.
Results: The efficiency entrapment value was 96.7 %, particle size analysis was 458±11.79 nm, and polydispersity index (PDI) was 0.65±0.07, with
spherical morphology as viewed in SEM. There was no significant difference between the nanochitosan supplemented group and the control group
in MCF-7 cells (p=0.067). However, the ratio of E2F1 to GAPDH was significantly lower than the control group after nanochitosan antimiR-106b-5p
was loaded at concentration 140 nmol (p=0.022) and 35 nmol (p=0.016).
Conclusion: Our nanochitosan formula is non-toxic to use in MCF-7 cell lines. Most importantly, as the formula was conjugated to synthetic
antimiR-106b-5p, the E2F1 expression decreased.
Keywords: Chitosan, Nanoparticle, miR-106b-5p, Breast cancer, E2F1

Item Type: Other
Subjects: R Medicine > RS Pharmacy and materia medica
Divisi / Prodi: Fakultas Kedokteran > S1 - Kedokteran
Depositing User: Leonny Rizkita
Date Deposited: 27 Sep 2022 06:54
Last Modified: 10 Nov 2022 03:39
URI: http://eprints.uad.ac.id/id/eprint/37141

Actions (login required)

View Item View Item